Hughes, D., Boyd, S., Giraldo, P., Gonzalez, D., Holida, M., Goker-Alpan, O., … Chertkoff, R. (2017). One-year follow up of Fabry disease patients treated by IV administration of a plant derived alpha-Gal-A enzyme: safety and efficacy. In Molecular Genetics and Metabolism (Vol. 120, pp. S68–S68). Elsevier BV. https://doi.org/10.1016/j.ymgme.2016.11.158

Hughes, Derralynn, Simeon Boyd, Pilar Giraldo, Derlis Gonzalez, Myrl Holida, Ozlem Goker-Alpan, Gustavo Maegawa, et al. “One-year follow up of Fabry disease patients treated by IV administration of a plant derived alpha-Gal-A enzyme: safety and efficacy.” In Molecular Genetics and Metabolism, 120:S68–S68. Elsevier BV, 2017. https://doi.org/10.1016/j.ymgme.2016.11.158.

Hughes D, Boyd S, Giraldo P, Gonzalez D, Holida M, Goker-Alpan O, et al. One-year follow up of Fabry disease patients treated by IV administration of a plant derived alpha-Gal-A enzyme: safety and efficacy. In: Molecular Genetics and Metabolism. Elsevier BV; 2017. p. S68–S68.

Hughes, Derralynn, et al. “One-year follow up of Fabry disease patients treated by IV administration of a plant derived alpha-Gal-A enzyme: safety and efficacy.” Molecular Genetics and Metabolism, vol. 120, no. 1–2, Elsevier BV, 2017, pp. S68–S68. Crossref, doi:10.1016/j.ymgme.2016.11.158.

Hughes D, Boyd S, Giraldo P, Gonzalez D, Holida M, Goker-Alpan O, Maegawa G, Atta M, Nicholls K, Schiffmann R, Tuffaha A, Barisoni L, Colvin R, Jannette JC, Krupko J, Szlaifer M, Brill-Almon E, Chertkoff R. One-year follow up of Fabry disease patients treated by IV administration of a plant derived alpha-Gal-A enzyme: safety and efficacy. Molecular Genetics and Metabolism. Elsevier BV; 2017. p. S68–S68.